首页> 美国卫生研究院文献>other >An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
【2h】

An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy

机译:通过强度调节放疗治疗46 yy的选择性放射剂量是可行的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT).In total, 504 patients with nondisseminated NPC who underwent magnetic resonance imaging before radical IMRT between 2000 and 2008 were retrospectively reviewed. The patients were classified into 2 groups based on the ENI dose: low ENI when the ENI dose was 46 Gy (n = 446) and high ENI when the ENI doses were 50 to 60 Gy (n = 58). All the patients in both the groups received a median dose of 72 Gy to the gross tumor and involved nodes. The fraction size was 2 Gy per fraction. Matching was performed between low ENI and high ENI in a 2:1 ratio, and the matching criteria were N-stage, T-stage, treatment modality, pathology classification, sex, and age.The median follow-up for all patients was 63.5 months. In all patients, the 5-year progression-free survival (PFS), local control (LC), regional control (RC), distant metastasis-free survival (DMFS), overall survival (OS), and cancer-specific survival (CSS) for low ENI and high ENI patients were 69.0% and 63.2% (P = 0.331), 89.0% and 83.9% (P = 0.235), 90.1% and 85.2% (P = 0.246), 86.8% and 76.6% (P = 0.056), 77.5% and 80.8% (P = 0.926), and 84.4% and 82.5% (P = 0.237), respectively. In the matched-pair analysis, the 5-year PFS, LC, RC, DMFS, OS, and CSS for matched low ENI and high ENI patients were 74.1% and 63.2% (P = 0.134), 92.0% and 83.9% (P = 0.152), 90.1% and 85.2% (P = 0.356), 86.2% and 76.6% (P = 0.125), 87.0% and 80.8% (P = 0.102), and 88.6% and 82.5% (P = 0.080), respectively. In the multivariable analysis for all patients, the ENI group was not a significant factor for PFS, LC, RC, DMFS, OS, and CSS.A low ENI dose of 46 Gy in 23 fractions is feasible in NPC patients treated with IMRT, and this concept should be validated in the prospective studies.
机译:这项研究的目的是比较经强度调制放疗(IMRT)治疗的鼻咽癌(NPC)患者不同剂量的选择性颈部照射(ENI)的治疗结果。总共504例未扩散的NPC接受了磁疗回顾性回顾了2000年至2008年进行彻底IMRT之前的磁共振成像。根据ENI剂量将患者分为两组:当ENI剂量为46 Gy(n == 446)时为低ENI;当ENI剂量为50至60 Gy(n == 58)时为高ENI。两组中的所有患者接受的总肿瘤中位剂量为72 Gy。馏分大小为每馏分2 Gy。低ENI与高ENI以2:1的比例进行匹配,匹配标准为N期,T期,治疗方式,病理学分类,性别和年龄。所有患者的中位随访率为63.5。个月。在所有患者中,其5年无进展生存期(PFS),局部对照(LC),区域对照(RC),远处无转移生存期(DMFS),总生存期(OS)和癌症特异性生存期(CSS)低ENI和高ENI患者分别为69.0%和63.2%(P = 0.331),89.0%和83.9%(P = 0.235),90.1%和85.2%(P = 0.246),86.8%和76.6%(P = 0.056),77.5%和80.8%(P = 0.926),84.4%和82.5%(P = 0.237)。在配对分析中,匹配的低ENI和高ENI患者的5年PFS,LC,RC,DMFS,OS和CSS分别为74.1%和63.2%(P = 0.134),92.0%和83.9%(P = 0.152),90.1%和85.2%(P = 0.356),86.2%和76.6%(P = 0.125),87.0%和80.8%(P = 0.102),以及88.6%和82.5%(P = 0.080) 。在所有患者的多变量分析中,ENI组不是PFS,LC,RC,DMFS,OS和CSS的显着因素。在IMRT治疗的NPC患者中,将ENI剂量低至23 G分数为46 Gy是可行的,并且该概念应在前瞻性研究中得到验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号